These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 9345394)

  • 41. [Interferon-beta in treatment of relapsing multiple sclerosis].
    Hartung HP; Hohlfeld R
    Nervenarzt; 1994 Feb; 65(2):139-45. PubMed ID: 8164769
    [No Abstract]   [Full Text] [Related]  

  • 42. [Current therapy of multiple sclerosis].
    Vass K; Schmied M
    Wien Med Wochenschr; 1996; 146(19-20):514-9. PubMed ID: 9082651
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Treatment of multiple sclerosis using recombinant interferon-beta].
    Polman CH; Barkhof F; van Loenen AC; Lucas CJ; Koetsier JC
    Ned Tijdschr Geneeskd; 1994 Jan; 138(1):7-10. PubMed ID: 8289963
    [No Abstract]   [Full Text] [Related]  

  • 44. Treatment of multiple sclerosis with various interferons: the cons.
    Johnson KP
    Neurology; 1988 Jul; 38(7 Suppl 2):62-5. PubMed ID: 3133576
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Multiple sclerosis clinical trials: old and new challenges.
    Noseworthy JH
    Semin Neurol; 1998; 18(3):377-88. PubMed ID: 9817540
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Multiple sclerosis: early management.
    Zajicek J
    Br J Hosp Med; 1997 Feb 19-Mar 4; 57(4):137-40. PubMed ID: 9166373
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Assessment of two clinical trials: interferon-gamma therapy in severe injury.
    Mock CN; Dries DJ; Jurkovich GJ; Maier RV
    Shock; 1996 Apr; 5(4):235-40. PubMed ID: 8721381
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Double-blind study of true vs. sham plasmapheresis in patients being treated with immunosuppression for acute attacks of multiple sclerosis.
    Weiner HL; Dau PC; Khatri BO; Petajan J; Birnbaum G; McQuillen MP; Fosburg MT; Feldstein M; Orav J
    Prog Clin Biol Res; 1990; 337():283. PubMed ID: 2162062
    [No Abstract]   [Full Text] [Related]  

  • 49. Interferon beta treatment in multiple sclerosis: the European clinical trials.
    Comi G; Martinelli V; Filippi M
    Mult Scler; 1996 Jul; 1(6):317-20. PubMed ID: 9345407
    [No Abstract]   [Full Text] [Related]  

  • 50. Beta interferons in clinically isolated syndromes: a meta-analysis.
    Melo A; Rodrigues B; Bar-Or A
    Arq Neuropsiquiatr; 2008 Mar; 66(1):8-10. PubMed ID: 18392405
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Identity of interferon-beta1a product in multiple sclerosis study.
    Wolf WW
    Ann Neurol; 1997 Apr; 41(4):560. PubMed ID: 9124816
    [No Abstract]   [Full Text] [Related]  

  • 52. There are no alternatives to double-blind, controlled trials.
    Noseworthy JH
    Neurology; 1988 Jul; 38(7 Suppl 2):76-9. PubMed ID: 3290719
    [No Abstract]   [Full Text] [Related]  

  • 53. Alternatives to randomized clinical trials.
    Ellison GW; Mickey MR; Myers LW
    Neurology; 1988 Jul; 38(7 Suppl 2):73-5. PubMed ID: 3290718
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Interferon beta treatment for multiple sclerosis.
    O'Connor P
    Lancet; 1999 Feb; 353(9151):496; author reply 497-8. PubMed ID: 9989742
    [No Abstract]   [Full Text] [Related]  

  • 55. Immunoadsorption (IA) versus plasma exchange (PE) in multiple sclerosis--first results of a double blind controlled trial.
    Schmitt E; Behm E; Buddenhagen F; Ernst B; Hitzschke B; Kracht M; Korten G; Kundt G; Meyer-Rienecker H; Osten B
    Prog Clin Biol Res; 1990; 337():289-92. PubMed ID: 2191322
    [No Abstract]   [Full Text] [Related]  

  • 56. Interferon beta treatment for multiple sclerosis.
    Goodin DS
    Lancet; 1999 Feb; 353(9151):495-6; author reply 497-8. PubMed ID: 9989741
    [No Abstract]   [Full Text] [Related]  

  • 57. [Interferon-beta 1a in therapy of relapsing-remitting multiple sclerosis].
    Hartung HP; Hohlfeld R
    Nervenarzt; 1997 Jun; 68(6):525-7. PubMed ID: 9312688
    [No Abstract]   [Full Text] [Related]  

  • 58. Interferon beta treatment for multiple sclerosis.
    Galazka A
    Lancet; 1999 Feb; 353(9151):495; author reply 497-8. PubMed ID: 9989740
    [No Abstract]   [Full Text] [Related]  

  • 59. Systemic recombinant alpha-2 interferon therapy in relapsing multiple sclerosis.
    Camenga DL; Johnson KP; Alter M; Engelhardt CD; Fishman PS; Greenstein JI; Haley AS; Hirsch RL; Kleiner JE; Kofie VY
    Arch Neurol; 1986 Dec; 43(12):1239-46. PubMed ID: 3535752
    [TBL] [Abstract][Full Text] [Related]  

  • 60. New treatments and azathioprine in multiple sclerosis.
    Palace J; Rothwell P
    Lancet; 1997 Jul; 350(9073):261. PubMed ID: 9242805
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.